Results 151 to 160 of about 48,143 (212)

Modulation of spasmogen‐stimulated Ins(1,4,5)P₃ generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle [PDF]

, 1998
R. A. John Challiss, David Adams, Rajendra Mistry, C. D. Nicholson   +3 more
openalex   +1 more source

Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model. [PDF]

Neurotherapeutics, 2019
Mollá B, Muñoz-Lasso DC, Calap P, Fernandez-Vilata A, de la Iglesia-Vaya M, Pallardó FV, Moltó MD, Palau F, Gonzalez-Cabo P.   +8 more
europepmc   +1 more source

Effects of Various Selective Phosphodiesterase Inhibitors on Muscle Contractility in Guinea Pig Ileal Longitudinal Smooth Muscle

, 1997
T Kaneda, Kazumasa Shimizu, Shinjiro Nakajyo, Norimoto Urakawa   +3 more
openalex   +2 more sources

Rolipram, a Phosphodiesterase-4-Selective Inhibitor, Promotes the Survival of Cultured Rat Dopaminergic Neurons.

, 1997
Nobuyuki Yamashita, Akiko Hayashi, Jun Baba, Aiko Sawa   +3 more
openalex   +1 more source

Characterization of phosphodiesterase 4 in guinea‐pig macrophages: multiple activities, association states and sensitivity to selective inhibitors [PDF]

, 1998
John J. Kelly, Peter J. Barnes, Mark A. Giembycz   +2 more
openalex   +1 more source

E4021, A Novel cGMP Phosphodiesterase (PDE5) Inhibitor, Improves Pulmonary Hemodynamics in Newborn Lambs with PPHN † 1645 [PDF]

, 1998
Robert C Dukarm, James A. Russell, Sylvia F. Gugino, Frederick C. Morin, Robin H. Steinhorn   +4 more
openalex   +1 more source

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease. [PDF]

Front Aging Neurosci, 2019
Cuadrado-Tejedor M, Pérez-González M, García-Muñoz C, Muruzabal D, García-Barroso C, Rabal O, Segura V, Sánchez-Arias JA, Oyarzabal J, Garcia-Osta A.   +9 more
europepmc   +1 more source

Effects of a non-xanthine adenosine antagonist. CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice

, 1995
Masahiro Imaizumt, Shuichi Miyazaki, Haruhiko Machida, Kenji Onodera   +3 more
openalex   +1 more source

Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer. [PDF]

J Cancer, 2017
Domvri K, Zarogoulidis K, Zogas N, Zarogoulidis P, Petanidis S, Porpodis K, Kioseoglou E, Hohenforst-Schmidt W.   +7 more
europepmc   +1 more source

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. [PDF]

Cochrane Database Syst Rev, 2018
Pattanaik S, Mavuduru RS, Panda A, Mathew JL, Agarwal MM, Hwang EC, Lyon JA, Singh SK, Mandal AK.   +8 more
europepmc   +1 more source